Corcept Therapeutics Ownership | Who Owns Corcept Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Corcept Therapeutics Ownership Summary


Corcept Therapeutics is owned by 79.73% institutional investors, 11.46% insiders, and 8.81% retail investors. Blackrock is the largest institutional shareholder, holding 16.09% of CORT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.38% of its assets in Corcept Therapeutics shares.

CORT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCorcept Therapeutics79.73%11.46%8.81%
SectorHealthcare Stocks 50.62%12.41%36.97%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock16.54M16.09%$537.36M
Blackrock funding, inc. /de12.43M11.90%$1.08B
Vanguard group9.49M9.17%$330.42M
Ingalls & snyder7.93M7.60%$689.90M
Renaissance5.26M5.04%$457.50M
Vanguard capital management4.17M4.00%$362.80M
Parallel advisors3.96M3.79%$344.51M
Fmr3.34M3.20%$290.21M
State street3.28M3.14%$285.15M
Aqr capital management2.58M2.47%$224.55M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ingalls & snyder7.93M18.83%$689.90M
Tanaka capital management111.21K16.64%$9.24M
Checkpoint capital392.33K10.92%$32.61M
Propel bio management136.50K6.21%$11.87M
Tang capital management1.50M5.92%$130.43M
Parallel advisors3.96M5.25%$344.51M
Bioimpact capital771.03K4.09%$67.04M
Birchview capital, lp57.20K2.33%$4.97M
Boxer capital management335.50K2.20%$29.17M
O'neil global advisors98.33K1.91%$8.55M

Top Buyers

HolderShares% AssetsChange
Aqr capital management2.58M0.08%2.18M
Sixth street partners management company1.16M0.01%1.16M
Fuller & thaler asset management710.11K0.17%710.11K
Jacobs levy equity management695.53K0.22%695.53K
Emerald advisers748.33K1.53%542.77K

Top Sellers

HolderShares% AssetsChange
Novo---2.41M
Td asset management---994.84K
Ikarian capital---994.50K
Epoch investment partners---816.65K
Sio capital management---674.76K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company1.16M0.01%1.16M$100.65M
Fuller & thaler asset management710.11K0.17%710.11K$61.74M
Jacobs levy equity management695.53K0.22%695.53K$60.48M
Norges bank487.06K0.00%487.06K$42.35M
Granite investment partners172.23K0.77%172.23K$14.98M

Sold Out

HolderChange
Tfc financial management-1.00
Dunhill financial-1.00
Tortoise investment management-1.00
Western wealth management-2.00
Root financial partners-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202644620.87%83,266,7454.66%791.36%27753.04%110-14.73%
Mar 31, 2026178-57.31%22,402,023-70.75%210.39%71-61.41%72-54.43%
Dec 31, 2025281-37.56%56,456,655-26.85%540.99%115-47.25%111-24.49%
Sep 30, 2025427-0.93%76,942,4182.16%731.41%209-5.86%137-9.87%
Jun 30, 2025432-3.79%78,890,554-3.87%751.22%221-7.14%15410.79%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.82M5.38%-2.31K
Vanguard Total Stock Mkt Idx Inv2.89M2.70%11.26K
Vanguard MStar Total Stk Mkt Idx Invest2.90M2.69%9.08K
Vanguard US Total Market Shares ETF2.83M2.68%213.93K
Vanguard Morn Total Stk Mkt Idx Investor2.89M2.68%11.26K
Vanguard Small Cap Index2.10M1.94%5.34K
iShares Russell 2000 ETF2.03M1.91%-
Fidelity Contrafund1.32M1.22%131.29K
Vanguard Small Cap Growth Index Inv1.21M1.13%38.79K
Vanguard MStar Small Cap Growth Indx Inv1.21M1.12%5.40K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 26, 2026Park Kimberly-Sell$3.27M
Aug 25, 2026Maduck Sean See RemarksSell$739.97K
Aug 25, 2026Maduck Sean See RemarksSell$3.15M
Aug 18, 2026MAHONEY DAVID L-Sell$838.71K
Aug 18, 2026MAHONEY DAVID L-Sell$585.48K

Insider Transactions Trends


DateBuySell
2026 Q3-44
2026 Q2-18
2026 Q125
2025 Q4-26
2025 Q3-31

CORT Ownership FAQ


Who owns the most shares of Corcept Therapeutics?

Corcept Therapeutics’s largest shareholders are Blackrock (16.54M shares, 16.09%), Blackrock funding, inc. /de (12.43M shares, 11.90%), and Vanguard group (9.49M shares, 9.17%). Together, they hold 37.16% of Corcept Therapeutics’s total shares outstanding.

Does Blackrock own Corcept Therapeutics?

Yes, BlackRock owns 16.09% of Corcept Therapeutics, totaling 16.54M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 537.36M$. In the last quarter, BlackRock decreased its holdings by -287K shares, a -1.71% change.

Who is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested?

Ingalls & snyder is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested, with 18.83% of its assets in 7.93M Corcept Therapeutics shares, valued at 689.9M$.

Who is the top mutual fund holder of Corcept Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Corcept Therapeutics shares, with 5.38% of its total shares outstanding invested in 5.82M Corcept Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools